BRPI0510290A - partìculas ou agregado nanoparticulado compósito biocompatìvel, seu processo de produção, composição farmacêutica ou de diagnóstico e utilização de partìculas ou agregados nanoparticulados ou de uma composição - Google Patents
partìculas ou agregado nanoparticulado compósito biocompatìvel, seu processo de produção, composição farmacêutica ou de diagnóstico e utilização de partìculas ou agregados nanoparticulados ou de uma composiçãoInfo
- Publication number
- BRPI0510290A BRPI0510290A BRPI0510290-1A BRPI0510290A BRPI0510290A BR PI0510290 A BRPI0510290 A BR PI0510290A BR PI0510290 A BRPI0510290 A BR PI0510290A BR PI0510290 A BRPI0510290 A BR PI0510290A
- Authority
- BR
- Brazil
- Prior art keywords
- particles
- composition
- nanoparticulate particles
- aggregates
- aggregate
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 239000002245 particle Substances 0.000 title abstract 4
- 239000002131 composite material Substances 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000003745 diagnosis Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000011246 composite particle Substances 0.000 abstract 1
- 230000005284 excitation Effects 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 150000002894 organic compounds Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/062—Photodynamic therapy, i.e. excitation of an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
- A61K49/0414—Particles, beads, capsules or spheres
- A61K49/0423—Nanoparticles, nanobeads, nanospheres, nanocapsules, i.e. having a size or diameter smaller than 1 micrometer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0661—Radiation therapy using light characterised by the wavelength of light used ultraviolet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N2005/1092—Details
- A61N2005/1098—Enhancing the effect of the particle by an injected agent or implanted device
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nanotechnology (AREA)
- Organic Chemistry (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Dispersion Chemistry (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Paints Or Removers (AREA)
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0405036A FR2869803B1 (fr) | 2004-05-10 | 2004-05-10 | Particules activables, preparation et utilisations |
FR0405036 | 2004-05-10 | ||
PCT/FR2005/001145 WO2005120590A1 (fr) | 2004-05-10 | 2005-05-09 | Particules activables, preparation et utilisations |
Publications (4)
Publication Number | Publication Date |
---|---|
BRPI0510290A true BRPI0510290A (pt) | 2007-10-30 |
BRPI0510290A8 BRPI0510290A8 (pt) | 2019-01-02 |
BRPI0510290B1 BRPI0510290B1 (pt) | 2021-06-01 |
BRPI0510290B8 BRPI0510290B8 (pt) | 2021-10-19 |
Family
ID=34945762
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0510290A BRPI0510290B8 (pt) | 2004-05-10 | 2005-05-09 | Partícula ou agregado nanoparticulado compósito biocompatível, seu processo de produção, composição farmacêutica ou de diagnóstico e utilização de partículas ou agregados nanoparticulados ou de uma composição |
Country Status (25)
Country | Link |
---|---|
US (2) | US9162079B2 (pt) |
EP (1) | EP1744789B1 (pt) |
JP (1) | JP5150251B2 (pt) |
KR (2) | KR101234334B1 (pt) |
CN (1) | CN100592921C (pt) |
AT (1) | ATE403444T1 (pt) |
AU (1) | AU2005251499B2 (pt) |
BR (1) | BRPI0510290B8 (pt) |
CA (1) | CA2564197C (pt) |
CY (1) | CY1108369T1 (pt) |
DE (1) | DE602005008731D1 (pt) |
DK (1) | DK1744789T3 (pt) |
EA (1) | EA010246B1 (pt) |
ES (1) | ES2312004T3 (pt) |
FR (1) | FR2869803B1 (pt) |
HK (1) | HK1099508A1 (pt) |
HR (1) | HRP20080534T3 (pt) |
IL (1) | IL178877A (pt) |
MX (1) | MXPA06013095A (pt) |
PL (1) | PL1744789T3 (pt) |
PT (1) | PT1744789E (pt) |
RS (1) | RS50615B (pt) |
SI (1) | SI1744789T1 (pt) |
WO (1) | WO2005120590A1 (pt) |
ZA (1) | ZA200610255B (pt) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2867180B1 (fr) | 2004-03-02 | 2006-06-16 | Univ Claude Bernard Lyon | Nanoparticules hybrides comprenant un coeur de ln203 porteuses de ligands biologiques et leur procede de preparation |
FR2869803B1 (fr) | 2004-05-10 | 2006-07-28 | Nanobiotix Sarl | Particules activables, preparation et utilisations |
FR2877571B1 (fr) * | 2004-11-05 | 2007-04-13 | Nanobiotix Sarl | Nanoparticules pourvues d'un element de ciblage intracellulaire, preparation et utilisations |
WO2006050579A1 (en) * | 2004-11-15 | 2006-05-18 | Australian Nuclear Science & Technology Organisation | Solid particles from controlled destabilisation of microemulsions |
US20070218049A1 (en) * | 2006-02-02 | 2007-09-20 | Wei Chen | Nanoparticle based photodynamic therapy and methods of making and using same |
EP2000150B1 (en) * | 2006-03-24 | 2016-07-13 | Toto Ltd. | Titanium oxide complex particle, dispersion solution of the particle, and process for production of the particle |
EP1852107A1 (en) * | 2006-04-19 | 2007-11-07 | Nanobiotix | Magnetic nanoparticles compositions and uses thereof |
EP1920784A1 (en) * | 2006-11-13 | 2008-05-14 | Koninklijke Philips Electronics N.V. | Radiation sensitizers in ionizing radiation therapy and imaging |
US8951561B2 (en) | 2007-08-06 | 2015-02-10 | Duke University | Methods and systems for treating cell proliferation disorders using plasmonics enhanced photospectral therapy (PEPST) and exciton-plasmon enhanced phototherapy (EPEP) |
US9488916B2 (en) | 2007-04-08 | 2016-11-08 | Immunolight, Llc. | Interior energy-activation of photo-reactive species inside a medium or body |
US9358292B2 (en) * | 2007-04-08 | 2016-06-07 | Immunolight, Llc | Methods and systems for treating cell proliferation disorders |
FR2922106B1 (fr) * | 2007-10-16 | 2011-07-01 | Univ Claude Bernard Lyon | Utilisation de nanoparticules a base de lanthanides comme agents radiosensibilisants. |
US8684898B2 (en) * | 2007-10-18 | 2014-04-01 | The Invention Science Fund I Llc | Ionizing-radiation-responsive compositions, methods, and systems |
US8164074B2 (en) * | 2007-10-18 | 2012-04-24 | The Invention Science Fund I, Llc | Ionizing-radiation-responsive compositions, methods, and systems |
US8168958B2 (en) * | 2007-10-18 | 2012-05-01 | The Invention Science Fund I, Llc | Ionizing-radiation-responsive compositions, methods, and systems |
US20090104113A1 (en) * | 2007-10-18 | 2009-04-23 | Searete Llc | Ionizing-radiation-responsive compositions, methods, and systems |
US9557635B2 (en) * | 2007-10-18 | 2017-01-31 | Gearbox, Llc | Ionizing-radiation-responsive compositions, methods, and systems |
US8227204B2 (en) * | 2007-10-18 | 2012-07-24 | The Invention Science Fund I, Llc | Ionizing-radiation-responsive compositions, methods, and systems |
GB2453860B (en) * | 2007-10-18 | 2011-03-16 | Searete Llc | Ionizing-radiation-responsive compositions,methods and systems |
US8529426B2 (en) * | 2007-10-18 | 2013-09-10 | The Invention Science Fund I Llc | Ionizing-radiation-responsive compositions, methods, and systems |
US9302116B2 (en) | 2007-11-06 | 2016-04-05 | Duke University | Non-invasive energy upconversion methods and systems for in-situ photobiomodulation |
CL2009000560A1 (es) | 2008-03-11 | 2010-02-19 | Univ Duke | Un metodo para endurecer un medio endurecible por radiacion que comprende colocar una composicion dentro de un objeto para ser endurecido, la aplicacion de al menos uno elegido entre rayos x, rayos gama o haz de electrones a traves del objeto y dentro de la composicion. |
WO2013009688A1 (en) | 2011-07-08 | 2013-01-17 | Bourke Frederic A | Phosphors and scintillators for light stimulation within a medium |
EP2268311A4 (en) | 2008-04-04 | 2014-08-27 | Immunolight Llc | NON-INVASIVE SYSTEMS AND METHOD FOR PHOTOBIOMODULATION IN SITU |
EP2130553A1 (en) * | 2008-06-05 | 2009-12-09 | Nanobiotix | Inorganic nanoparticles of high density to destroy cells in-vivo |
WO2010009106A1 (en) * | 2008-07-14 | 2010-01-21 | Bourke Frederic A Jr | Advanced methods and systems for treating cell proliferation disorders |
AU2009278007B2 (en) | 2008-07-31 | 2015-08-27 | Alma Mater Studiorum - Universita' Di Bologna | Active particles for bio-analytical applications and methods for their preparation |
CN102870235B (zh) * | 2009-11-10 | 2016-11-23 | 免疫之光有限责任公司 | 用于从包括用于上变频的射频、微波能量和磁感应源的各种能量源产生发射光的上下变频系统 |
GB0921596D0 (en) | 2009-12-09 | 2010-01-27 | Isis Innovation | Particles for the treatment of cancer in combination with radiotherapy |
ES2880840T3 (es) | 2010-05-06 | 2021-11-25 | Immunolight Llc | Composición de unión adhesiva y método de uso |
US9572880B2 (en) | 2010-08-27 | 2017-02-21 | Sienna Biopharmaceuticals, Inc. | Ultrasound delivery of nanoparticles |
TR201807153T4 (tr) | 2010-08-27 | 2018-06-21 | Sienna Biopharmaceuticals Inc | Hedefe yönelik termomodülasyon için bileşimler ve yöntemler. |
US9116246B2 (en) * | 2011-04-07 | 2015-08-25 | Stc.Unm | Thermal neutron detectors based on gadolinium-containing nanoscintillators |
JPWO2012153820A1 (ja) * | 2011-05-12 | 2014-07-31 | コニカミノルタ株式会社 | X線吸収蛍光ナノ粒子 |
US9693957B2 (en) | 2011-07-08 | 2017-07-04 | The University Of North Carolina At Chapel Hill | Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders |
WO2013035739A1 (ja) * | 2011-09-05 | 2013-03-14 | 株式会社Ihi | 温熱治療用材料、温熱治療用システム及び温熱治療方法 |
SG11201403096VA (en) | 2011-12-16 | 2014-07-30 | Nanobiotix | Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof |
IL296593B2 (en) | 2012-10-11 | 2024-04-01 | Nanocomposix Inc | Compositions of silver nanoparticle coating and methods |
MA38709A1 (fr) * | 2013-06-20 | 2018-05-31 | Nanobiotix | Compositions et procédés pour une utilisation en diagnostic médical |
SG11201510468TA (en) * | 2013-06-20 | 2016-01-28 | Nanobiotix | Compositions and methods for use in oncology |
FR3018451A1 (fr) * | 2014-03-13 | 2015-09-18 | Chromalys | Nanoparticules pour leur utilisation dans la detection de tumeurs mobiles |
WO2015149188A1 (en) * | 2014-04-03 | 2015-10-08 | The Governing Council Of The University Of Toronto | Multifunctional nanoparticle compositions and uses thereof |
US10806694B2 (en) | 2014-10-14 | 2020-10-20 | The University Of Chicago | Nanoparticles for photodynamic therapy, X-ray induced photodynamic therapy, radiotherapy, radiodynamic therapy, chemotherapy, immunotherapy, and any combination thereof |
CN107001031B (zh) | 2014-10-14 | 2019-11-15 | 芝加哥大学 | 一种金属有机框架、药物制剂及其在制备药物中的用途 |
EP3721887A1 (en) * | 2015-01-08 | 2020-10-14 | Purdue Research Foundation | Non-toxic formulations of radio-luminescent nanoparticles for use as cancer radio-sensitizing agents |
AR104806A1 (es) | 2015-05-28 | 2017-08-16 | Nanobiotix | Nanopartículas para uso como vacuna terapéutica |
US9770688B2 (en) | 2015-10-22 | 2017-09-26 | King Fahd University Of Petroleum And Minerals | Si—Y nanocomposite membrane and methods of making and use thereof |
JP7090034B2 (ja) | 2016-05-20 | 2022-06-23 | ザ ユニバーシティ オブ シカゴ | 化学療法、標的療法、光線力学療法、免疫療法及びそれらの任意の組み合わせのためのナノ粒子 |
US11590225B2 (en) | 2016-12-08 | 2023-02-28 | The Brigham And Women's Hospital, Inc. | Bismuth-gadolinium nanoparticles |
US10283476B2 (en) | 2017-03-15 | 2019-05-07 | Immunolight, Llc. | Adhesive bonding composition and electronic components prepared from the same |
CN111194232B (zh) | 2017-08-02 | 2023-01-31 | 芝加哥大学 | 纳米级金属有机层和金属有机纳米片 |
EP3849613A2 (en) | 2018-06-01 | 2021-07-21 | Tae Life Sciences | Biodegradable nanocarriers for neutron capture therapy and methods thereof |
US20240000940A1 (en) * | 2020-12-01 | 2024-01-04 | Nanobiotix S.A. | Porous, high-z and carbon-free particles as radioenhancers |
CN112655715A (zh) * | 2020-12-25 | 2021-04-16 | 杭州甜蜜按钮科技有限公司 | 一种哺乳期羊舍专用消毒剂的制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5985173A (en) * | 1997-11-18 | 1999-11-16 | Gray; Henry F. | Phosphors having a semiconductor host surrounded by a shell |
JP3490015B2 (ja) * | 1999-03-11 | 2004-01-26 | 関西ティー・エル・オー株式会社 | 化学的耐久性に優れた放射性微小球及びその製造方法 |
CA2399293C (en) * | 2000-02-08 | 2012-01-03 | Rice University | Optically-active nanoparticles for use in therapeutic and diagnostic methods |
ES2258527T3 (es) * | 2000-05-05 | 2006-09-01 | Bayer Technology Services Gmbh | Nanoparticulas impurificadas como biomarcadores. |
US20020127224A1 (en) * | 2001-03-02 | 2002-09-12 | James Chen | Use of photoluminescent nanoparticles for photodynamic therapy |
JP2007514736A (ja) * | 2003-12-17 | 2007-06-07 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 紫外線放射ナノ粒子を用いた放射線治療および医学画像 |
US8128908B2 (en) * | 2004-04-30 | 2012-03-06 | University Of Florida Research Foundation, Inc. | Nanoparticles and their use for multifunctional bioimaging |
FR2869803B1 (fr) | 2004-05-10 | 2006-07-28 | Nanobiotix Sarl | Particules activables, preparation et utilisations |
US20070218049A1 (en) * | 2006-02-02 | 2007-09-20 | Wei Chen | Nanoparticle based photodynamic therapy and methods of making and using same |
-
2004
- 2004-05-10 FR FR0405036A patent/FR2869803B1/fr not_active Expired - Fee Related
-
2005
- 2005-05-09 AT AT05769516T patent/ATE403444T1/de active
- 2005-05-09 DK DK05769516T patent/DK1744789T3/da active
- 2005-05-09 EA EA200602077A patent/EA010246B1/ru not_active IP Right Cessation
- 2005-05-09 CN CN200580014476A patent/CN100592921C/zh not_active Expired - Fee Related
- 2005-05-09 RS RSP-2008/0456A patent/RS50615B/sr unknown
- 2005-05-09 KR KR1020067023550A patent/KR101234334B1/ko active IP Right Grant
- 2005-05-09 CA CA2564197A patent/CA2564197C/fr active Active
- 2005-05-09 PT PT05769516T patent/PT1744789E/pt unknown
- 2005-05-09 US US11/579,867 patent/US9162079B2/en active Active
- 2005-05-09 AU AU2005251499A patent/AU2005251499B2/en not_active Ceased
- 2005-05-09 DE DE602005008731T patent/DE602005008731D1/de active Active
- 2005-05-09 ES ES05769516T patent/ES2312004T3/es active Active
- 2005-05-09 PL PL05769516T patent/PL1744789T3/pl unknown
- 2005-05-09 SI SI200530367T patent/SI1744789T1/sl unknown
- 2005-05-09 BR BRPI0510290A patent/BRPI0510290B8/pt not_active IP Right Cessation
- 2005-05-09 KR KR1020127027128A patent/KR20120123731A/ko not_active Application Discontinuation
- 2005-05-09 WO PCT/FR2005/001145 patent/WO2005120590A1/fr active Application Filing
- 2005-05-09 JP JP2007512273A patent/JP5150251B2/ja not_active Expired - Fee Related
- 2005-05-09 EP EP05769516A patent/EP1744789B1/fr active Active
- 2005-05-09 MX MXPA06013095A patent/MXPA06013095A/es active IP Right Grant
-
2006
- 2006-10-26 IL IL178877A patent/IL178877A/en unknown
- 2006-12-08 ZA ZA200610255A patent/ZA200610255B/xx unknown
-
2007
- 2007-02-28 HK HK07102261.1A patent/HK1099508A1/xx not_active IP Right Cessation
-
2008
- 2008-09-24 CY CY20081101047T patent/CY1108369T1/el unknown
- 2008-10-22 HR HR20080534T patent/HRP20080534T3/xx unknown
-
2015
- 2015-05-08 US US14/707,529 patent/US9433800B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0510290A (pt) | partìculas ou agregado nanoparticulado compósito biocompatìvel, seu processo de produção, composição farmacêutica ou de diagnóstico e utilização de partìculas ou agregados nanoparticulados ou de uma composição | |
Khajuria et al. | Accelerated bone regeneration by nitrogen-doped carbon dots functionalized with hydroxyapatite nanoparticles | |
Huja et al. | Remodeling dynamics in the alveolar process in skeletally mature dogs | |
Gupta et al. | Nanoscale deformation mechanisms in bone | |
ES2817048T3 (es) | Aleaciones de magnesio de elevada resistencia y bioabsorbibles | |
Kang et al. | Nanolayered hybrid mediates synergistic co-delivery of ligand and ligation activator for inducing stem cell differentiation and tissue healing | |
BRPI0918337A2 (pt) | composto, composição farmacêutica, método de tratamento, método para tratar uma doença ou condição causada, exacerbada ou resultante de um excesso de plaquetas ou ativação indesejada de plaquetas em um paciente, método para reduzir a contagem de plaquetas circulantes em um paciente e uso | |
ATE530168T1 (de) | Magnetische nanoteilchen-zusammensetzungen und ihre verwendungen | |
BR0309167A (pt) | Composto, processo para a produção de um composto, composição farmacêutica, uso do composto, método para o tratamento de um sujeito afetado por uma condição patológica ou doença e produto de combinação | |
Li et al. | A conductive photothermal non-swelling nanocomposite hydrogel patch accelerating bone defect repair | |
BRPI0905687A8 (pt) | composto da fórmula i ou i', composição farmacêutica, método de tratamento de um paciente com uma doença, uso do composto | |
Ferreira-Ermita et al. | Characterization and in vivo biocompatibility analysis of synthetic hydroxyapatite compounds associated with magnetite nanoparticles for a drug delivery system in osteomyelitis treatment | |
BRPI0606833A2 (pt) | uso de 2, 4-dihidróxi-3-metilbenzoato, medicamento para o tratamento da hiperplasia prostática, carcinoma de próstata ou da atrofia muscular espino-bulbar, 2,4-dihidróxi-3-metilbenzoato, processo para o isolamento do ácido atrárico a partir de um material biológico e processo para a sìntese de derivados do ácido atrárico | |
Furka et al. | Novel antimicrobial materials designed for the 3D printing of medical devices used during the COVID-19 crisis | |
Ilyas et al. | Microwave-assisted synthesis and evaluation of type 1 collagen–apatite composites for dental tissue regeneration | |
Takizawa et al. | A biomechanical comparison of three miniature locking plate systems in a rabbit radial and ulnar fracture model | |
Zhou et al. | Injectable ultrasound-powered bone-adhesive nanocomposite hydrogel for electrically accelerated irregular bone defect healing | |
Ellis | Nanodentistry: The benefits of nanotechnology in dentistry and its impact on oral health | |
Su et al. | Understanding the mechanics of the temporomandibular joint osteochondral interface from micro-and nanoscopic perspectives | |
Sari et al. | Injectable bone substitute synthesized from mangrove snail shell | |
Abualhasan et al. | Clinical properties and efficacy of MTA VS Biodentine VS GIC in repairing root perforations | |
Sales | Fabrico e caracterização mecânica de placas estabilizadoras de fraturas em material compósito polimérico | |
Toulou | EXTRUSION-BASED 3D-PRINTED QUERCETIN LOADED | |
Laviv et al. | Island Osteoperiosteal Flap Vitality when Isolated from Basal Bone by Silicone Interposition: An Experimental Study in Rabbit Tibia. | |
UTAMA et al. | THE CONTENT OF COMPOUND AND BIOACTIVE SUBSTANCE OF THE ROSELLA PETALS EXTRACT GEL TO ACCELERATE THE REMODELING PROCESS OF THE ALVEOLAR BONE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 09/05/2005, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
B09W | Correction of the decision to grant [chapter 9.1.4 patent gazette] |
Free format text: RETIFICA-SE O DEFERIMENTO NOTIFICADO NA RPI NO 2626 DE 04/05/2021. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: REFERENTE AO DESPACHO 16.1 PUBLICADO NA RPI 2630, QUANTO AO RELATORIO DESCRITIVO |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 18A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2722 DE 07-03-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |